Kee B L, Dadi H K, Tran-Paterson R, Quackenbush E J, Andrulis I L, Letarte M
Division of Immunology and Cancer Research, Hospital for Sick Children, Toronto, Canada.
J Cell Physiol. 1991 Sep;148(3):414-20. doi: 10.1002/jcp.1041480312.
The expression of CD10/CALLA is associated primarily with childhood leukemia of pre-B lymphocyte phenotype. We have compared the hybridization pattern of the CALLA gene from leukemic and normal cells digested with several restriction enzymes. No alterations were noticed with Eco RI, Sac I, Pvu II, Eco RV, Hind III, and Msp I. Since CALLA is also found on other malignancies, we analyzed DNA samples prepared from cell lines derived from leukemia, lymphoma, glioblastoma, retinoblastoma, and neuroblastoma. Normal restriction patterns were observed for all the lines regardless of their CALLA phenotype. Having demonstrated previously that CALLA was structurally identical to neutral endopeptidase 3.4.24.11 (NEP), we have now established a correlation between surface expression of CALLA and NEP activity on leukemia samples and on several cell lines. Malignant cells tested expressed a functionally active enzyme and no gross alteration was present in the CALLA gene. The CD44 gene is expressed on most cells of hemopoietic origin and on greater than 95% of cases of acute lymphoblastic leukemia and acute myeloblastic leukemia studied. It is also expressed on normal astrocytes and on malignant cells of glioma/astrocytoma types. We now report that a similar pattern of hybridization was observed with Sac I, Pvu II, and Eco RI for leukemic samples, normal cells, and malignant cell lines. A polymorphism was recently detected for CD44 using Hind III; leukemic cells and malignant lines also showed this normal polymorphism. Thus no deletion or insertion could be detected in the CD44 gene of leukemic cells and malignant lines, suggesting that no gross DNA alterations were involved. The correlation between surface expression and enzymatic activity of CD10/CALLA and the expression of CD44 on a variety of malignant cells would suggest that the structure and function of these two gene products are probably not altered by the process of transformation.
CD10/ CALLA的表达主要与前B淋巴细胞表型的儿童白血病相关。我们比较了用几种限制性内切酶消化的白血病细胞和正常细胞中CALLA基因的杂交模式。用Eco RI、Sac I、Pvu II、Eco RV、Hind III和Msp I未发现改变。由于CALLA也存在于其他恶性肿瘤中,我们分析了从白血病、淋巴瘤、胶质母细胞瘤、视网膜母细胞瘤和神经母细胞瘤的细胞系制备的DNA样本。所有细胞系无论其CALLA表型如何,均观察到正常的限制性模式。先前已证明CALLA在结构上与中性内肽酶3.4.24.11(NEP)相同,我们现在已在白血病样本和几种细胞系上建立了CALLA表面表达与NEP活性之间的相关性。测试的恶性细胞表达一种功能活跃的酶,且CALLA基因未出现明显改变。CD44基因在大多数造血起源细胞以及所研究的超过95%的急性淋巴细胞白血病和急性髓细胞白血病病例中表达。它也在正常星形胶质细胞以及胶质瘤/星形细胞瘤类型的恶性细胞中表达。我们现在报告,白血病样本、正常细胞和恶性细胞系用Sac I、Pvu II和Eco RI观察到类似的杂交模式。最近使用Hind III检测到CD44存在多态性;白血病细胞和恶性细胞系也显示出这种正常的多态性。因此,在白血病细胞和恶性细胞系的CD44基因中未检测到缺失或插入,表明未涉及明显的DNA改变。CD10/CALLA的表面表达与酶活性以及CD44在多种恶性细胞上的表达之间的相关性表明,这两种基因产物的结构和功能可能未因转化过程而改变。